LEADER 06259nam 22007575 450 001 9910765485003321 005 20231118094731.0 010 $a3-031-39928-5 024 7 $a10.1007/978-3-031-39928-2 035 $a(MiAaPQ)EBC30954472 035 $a(Au-PeEL)EBL30954472 035 $a(DE-He213)978-3-031-39928-2 035 $a(CKB)28893368800041 035 $a(EXLCZ)9928893368800041 100 $a20231118d2023 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBiology of Women?s Heart Health /$fedited by Lorrie Kirshenbaum, Inna Rabinovich-Nikitin 205 $a1st ed. 2023. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2023. 215 $a1 online resource (0 pages) 225 1 $aAdvances in Biochemistry in Health and Disease,$x2512-2150 ;$v26 311 08$aPrint version: Kirshenbaum, Lorrie Biology of Women's Heart Health Cham : Springer International Publishing AG,c2024 9783031399275 327 $aAttenuation of Bnip3 Mediated Doxorubicin-Induced Cell Death in Cardiac Myocytes -- Sex Dependent Regulation of Circadian Rhythms in Health and Disease -- Circadian Pharmacological Approach to Treat Myocardial Infarct -- GPER Function as a Determinant of the Progression of Atherosclerotic Disease in Women -- Novel Therapeutic Approach to Treat Cardiac-Rheumatology in Females -- Correlation between Sex, Immigration Status, Ethnicity, and Long-term Outcomes of Ischemic Stroke -- Risk Assessment and Predictive Modelling for The Heart-Brain Interface in Women -- Insomnia Interventions for Female Cardiac Patients -- Aortic Stenosis Progression, Cardiac Damage, and Survival: Comparison Between Men and Women -- Treatment and Management of Valvular Heart Disease and Cost-Effectiveness Analysis -- Association of Mortality and Acute Aortic Events with Ascending Aortic Aneurysm -- Improving Diagnosis and Treatment for Patients Who Suffer Spontaneous Coronary Artery Dissection (SCAD) -- Preeclampsia and Future Cardiovascular Health -- Cardiovascular Disease in Women with a History of Pregnancy Complications -- Hormone Replacement Treatment for Cardiovascular Disease -- Cardiovascular Mortality Following Early-Stage Breast Cancer -- Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease in Women -- Sex Differences in Cardiac Rehabilitation Enrollment -- Promoting Exercise and Physical Activity in Female Patients with Heart Disease -- Sex and Gender Differences in the Diagnosis, Treatment, and Outcomes of Coronary Artery Disease -- Sex Differences in Arterial Aging and its Implications on Cardiovascular Diseases -- Impact of a Novel Community-Based Lifestyle Intervention Program on Type 2 Diabetes and Cardiovascular Risk -- Clinical Outcomes Related to Heart Failure and Pulmonary Hypertension -- Examination of Health-Related Quality of Life in Women with Coronary Artery Disease -- The Risks and Benefits of Implantable Cardioverter-Defibrillator Generator Replacement -- The Effects and Roles of Estrogen in Managing Hypertension in Menopausal Women -- The Effects of Menopausal Hormone Therapy on the Vascular System -- Influence of Sex Differences in Non-Obstructive Coronary Artery Disease -- Diet1 and Resistance to High Cholesterol Levels and Cardiovascular Disease -- Interventions to Improve Clinical Outcomes Following Hospitalization for Heart Failure -- Sex-Dependent Cardioprotective Effects of the Phytoestrogen Resveratrol -- Blood Pressure Across a Woman's Life Cycle -- Women?s Fitness Levels and Heart Rate Response to Exercise -- Supervised Exercise Therapy Through Cardiac Rehabilitation following Peripheral Arterial Disease -- Sex Differences in ANT2-Mediated ATP Import into Mitochondria for Protection Against Hypoxia Lethal Injury. 330 $aCardiovascular disease (CVD) is the leading cause of morbidity and mortality in women and men worldwide and represents a major financial burden to world health care systems. Importantly, CVD has eclipsed cancer as the leading cause of death for women globally. Through advancements in research and clinical testing, the symptoms and risk factors for CVD have been well established for men, but not for women. Consequently, there is an immediate need for new innovative research that will bridge this gap and allow for improved early diagnosis and treatment of CVD in women. This book will serve as a guide for health care providers to better understand the physiological, biochemical, and genetic differences in heart disease in women with the goal of providing improved education, awareness and treatment of cardiovascular disease in women. The book will cover topics such as: sex dependent clinical outcomes of cardiovascular disease, cardiac protection by estrogen, cardiac health during menopause, cardiac rehabilitation programs, fitness and exercise, cardio-oncology, shift work and the CVD risk, and pregnancy related CVD. 410 0$aAdvances in Biochemistry in Health and Disease,$x2512-2150 ;$v26 606 $aCardiovascular system 606 $aPhysiology 606 $aCardiology 606 $aMedicine$xResearch 606 $aBiology$xResearch 606 $aMedical sciences 606 $aHealth 606 $aSex 606 $aCardiovascular Physiology 606 $aCardiology 606 $aBiomedical Research 606 $aHealth Sciences 606 $aGender and Health 615 0$aCardiovascular system. 615 0$aPhysiology. 615 0$aCardiology. 615 0$aMedicine$xResearch. 615 0$aBiology$xResearch. 615 0$aMedical sciences. 615 0$aHealth. 615 0$aSex. 615 14$aCardiovascular Physiology. 615 24$aCardiology. 615 24$aBiomedical Research. 615 24$aHealth Sciences. 615 24$aGender and Health. 676 $a616.10082 676 $a616.10082 700 $aKirshenbaum$b Lorrie$01448910 701 $aRabinovich-Nikitin$b Inna$01448911 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910765485003321 996 $aBiology of Women?s Heart Health$93644919 997 $aUNINA